
Monday, December 02, 2024 12:31:01 PM
per11th CircuitLaw $HCMC original💹infringement Complaints Valid💹
We now turn to $HCMCs amended complaint, which presents an even stronger case in favor of $HCMC.
In Court Under Oath $PM made up Mockups in Self-serving way to show features that are not shown or discussed in Hammel itself.
$PM recognized Hammel’s disclosure was lacking
https://www.pacermonitor.com/case/37309414/Healthier_Choices_Management_Corp_v_Philip_Morris_USA,_Inc_et_al

Recent HCMC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 07:40:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 04/24/2025 08:00:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/14/2025 09:21:25 PM
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 02/19/2025 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/27/2025 09:44:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2024 10:00:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 08:59:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 09:30:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/12/2024 08:20:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 03:36:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 06:55:50 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 07/29/2024 05:35:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 09:23:51 PM
FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM